pirlimycin

Subscribe to Selected New Research on pirlimycin

17 relevant articles (7 outcomes, 3 trials/studies) found for this Bio-Agent

Description: RN given refers to (mono-HCl(2S-cis)-isomer)

Also Known As:

U 57930E; U-57930E; cis-4-ethyl-L-picecolic acid amide of 7-deoxy-7(S)chloromethylthio lincosaminide hydrochloride; pirlimycin monohydrochloride monohydrate, (2S-cis)-isomer; pirlimycin monohydrochloride, (2R-cis)-isomer; L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((4-ethyl-2-piperidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-cis)-

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

Experts

1.	Gillespie, Barbara E: 3 articles (05/2007 - 01/2002)
2.	Oliver, Stephen P: 3 articles (05/2007 - 01/2002)
3.	Dowlen, Henry H: 3 articles (05/2007 - 01/2002)
4.	Moorehead, Hugh: 3 articles (05/2007 - 01/2002)
5.	Johnson, David L: 3 articles (05/2007 - 01/2002)
6.	Hallberg, John W: 2 articles (05/2007 - 01/2002)
7.	Lewis, Mark J: 2 articles (05/2007 - 01/2002)
8.	Lamar, Ken C: 2 articles (01/2003 - 01/2002)
9.	Lunn, Phillip: 2 articles (01/2003 - 01/2002)
10.	Ivey, Susan J: 2 articles (01/2003 - 01/2002)

Related Diseases

1.	Mastitis 02/01/2005 - "These studies were conducted to evaluate the efficacy of daily intramammary infusions with 50 mg of pirlimycin hydrochloride for the treatment of subclinical mastitis. " 06/01/2009 - "CONCLUSIONS AND CLINICAL RELEVANCE: Many target pathogens from cows with subclinical mastitis were eliminated without treatment, and treatment with pirlimycin did not improve the treatment success rate. " 06/01/2009 - "PROCEDURES: Cows with positive results for a California mastitis test (CMT) were assigned to receive 50 mg of pirlimycin via intramammary administration into each CMT-positive mammary gland every 24 hours for 2 consecutive days or no treatment. " 06/01/2009 - "OBJECTIVE: To determine the association between results of in vitro antimicrobial susceptibility tests and outcomes in cows that received intramammary treatment with pirlimycin hydrochloride for subclinical mastitis associated with gram-positive pathogens. " 06/01/2009 - "Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens." Order ALL the reference details at left...
2.	Infection 01/01/2002 - "Results of this study indicate that extended pirlimycin therapy was effective in eliminating intramammary infections caused by environmental streptococci and S. " 01/01/2003 - "uberis intramammary infections were eliminated in 58.1% of the infected quarters treated with the pirlimycin 2-day regimen, 68.8% for the 5-day regimen, and 80.0% for the 8-day regimen. " 01/01/2003 - "Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle." 01/01/2002 - "Efficacy of pirlimycin therapy against intramammary infections caused by environmental Streptococcus spp and S. " 01/01/2002 - "Fifty-one chronically infected lactating dairy cows were used to evaluate the efficacy of extended pirlimycin therapy regimens for treatment of intramammary infections by environmental Streptococcus spp and Staphylococcus aureus. " Order ALL the reference details at left...
3.	Bovine Mastitis 05/01/1993 - "Pirlimycin is an analog of clindamycin that will be recommended for therapy of bovine mastitis. " 01/01/2007 - "OBJECTIVES: As known from other lincosamides and 16-membered macrolides, the antimicrobial agents pirlimycin, spiramycin and tylosin, which are frequently used for the therapy of bovine mastitis, cannot induce the expression of the resistance gene erm(C). " Order ALL the reference details at left...
4.	Acquired Immunodeficiency Syndrome (AIDS) 01/01/2004 - "Summaries follow of the Committee's evaluations of toxicological and residue data on a variety of veterinary drugs: five antibacterial agents (cefuroxime, chloramphenicol, flumequine, lincomycin, pirlimycin), four insecticides (cyhalothrin, cypermethrin and alpha-cypermethrin, doramectin, phoxim), and two production aids (melengestrol acetate, ractopamine). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Penicillins (Penicillin)
2.	Novobiocin (Streptonivicin)
3.	Lincosamides
4.	Veterinary Drugs (Veterinary Drug)
5.	Macrolides
6.	Tylosin
7.	Spiramycin
8.	Melengestrol Acetate (Melengestrol)
9.	Lincomycin (Lincocin)
10.	Insecticides

Best Treatments:
Research Summary Report
on Mastitis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 129 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>